English

LIPOCINE INC.

EDGAR

LPCN Current report (8-K) · filed 2026-10-20

Annual consolidated revenue for 2025: about USD 1.977M, using the latest reported figures. The previous period, 2024, was about USD 11.2M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

190 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 190099 USD Source

Operating margin

-1,495.14%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -2842246 USD Source
Revenue: 190099 USD Source

Operating cash flow

-3.03 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -5285564 USD Source
Operating Cash Flow: -2257137 USD Source

Cash and cash equivalents: 4.98 million USD 2026-06-30 Source
Exact value

4979430 USD
Long-term debt including current maturities: 833 thousand USD 2022-03-31 Source
Exact value

833000 USD
Shares outstanding: 8.24 million shares 2026-06-30 Source
Exact value

8244253 shares

Reported share-count change

53.41% · 2.87 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

5374095 shares · 2025-06-30· Source
8244253 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-20.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2025-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2024-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2021-12-31
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-82.3%

Prior period

USD 11.2 million

2024-01-01 – 2024-12-31
Current period

USD 1.98 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1976677 − 11198144 = -9221467 USD

11198144 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1976677 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · LIPOCINE INC. · 2025-12-31 LIPOCINE INC. (edgar:1535955) Year-over-year change in Revenue: -9221467 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1976677 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1350104 Filing: 000149315226009411 Input fundies:Revenue: 11198144 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1350789 Filing: 000149315226009411
The citation records this snapshot. The page link may show a newer release later.
Net income
-115,371.9%

Prior period

USD 8,352

2024-01-01 – 2024-12-31
Current period

−USD 9.63 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-9627505 − 8352 = -9635857 USD

8352 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-9627505 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · LIPOCINE INC. · 2025-12-31 LIPOCINE INC. (edgar:1535955) Year-over-year change in Net income: -9635857 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -9627505 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1482096 Filing: 000149315226009411 Input fundies:NetIncome: 8352 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1482667 Filing: 000149315226009411
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 8.54 million

Prior period

−USD 1.22 million

2024-01-01 – 2024-12-31
Current period

−USD 9.76 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-9760721 − -1221233 = -8539488 USD

-1221233 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-9760721 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · LIPOCINE INC. · 2025-12-31 LIPOCINE INC. (edgar:1535955) Year-over-year change in Operating cash flow: -8539488 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -9760721 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1291719 Filing: 000149315226009411 Input fundies:OperatingCashFlow: -1221233 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1292438 Filing: 000149315226009411
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 1.98 million 100% of revenue
Operating costs Derived USD 12.35 million 625% of revenue
Operating income −USD 10.37 million −525% of revenue
Tax, interest and other Derived −USD 743,874 −38% of revenue
Net income −USD 9.63 million −487% of revenue

Cash

Operating cash flow −USD 9.76 million −494% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Operating loss: operating costs were 2,746% of revenue.
2021 Net loss: net income was −3.9% of revenue.
2022 Operating loss: operating costs were 2,524% of revenue.
2023 Not shown: operating income or net income is not reported.
2024 Operating loss: operating costs were 110% of revenue.
2025 Operating loss: operating costs were 625% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	0	19186834 Derived	-19186834	-215326 Derived	-18971508	-18341588 Derived	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -19186834 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -18971508 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -18281938 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 59650 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	21217976 Derived	-21217976	-235116 Derived	-20982860	-16702015 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -21217976 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -20982860 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -16702015 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 0 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	428031	11753850 Derived	-11325819	334203 Derived	-11660022	-12078825 Derived	Source 2018-01-01 – 2018-12-31: 428031 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -11325819 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -11660022 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -12078825 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	16140838	12995335 Derived	3145503	3779902 Derived	-634399	-4418894 Derived	Source 2021-01-01 – 2021-12-31: 16140838 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 3145503 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -634399 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -4411303 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 7591 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	500000	12619375 Derived	-12119375	-1360739 Derived	-10758636	-12102650 Derived	Source 2022-01-01 – 2022-12-31: 500000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -12119375 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -10758636 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -11968819 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 133831 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	-2850818	15080139 Derived	-17930957	-1578875 Derived	-16352082	-11879158 Derived	Source 2023-01-01 – 2023-12-31: -2850818 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -17930957 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -16352082 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -11865991 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 13167 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	11198144	12353179 Derived	-1155035	-1163387 Derived	8352	-1311319 Derived	Source 2024-01-01 – 2024-12-31: 11198144 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -1155035 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 8352 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -1221233 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 90086 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	1976677	12348056 Derived	-10371379	-743874 Derived	-9627505	Unavailable	Source 2025-01-01 – 2025-12-31: 1976677 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -10371379 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -9627505 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -9760721 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	428031	Revenue: 428031 Open source
20212021-12-31	Revenue	16140838	Revenue: 16140838 Open source
20222022-12-31	Revenue	500000	Revenue: 500000 Open source
20232023-12-31	Revenue	-2850818	Revenue: -2850818 Open source
20242024-12-31	Revenue	11198144	Revenue: 11198144 Open source
20252025-12-31	Revenue	1976677	Revenue: 1976677 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-82.3% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 428031 Open source Revenue: 0 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 16140838 Open source
20222022-12-31	Year over year	-96.9%	Revenue: 500000 Open source Revenue: 16140838 Open source
20232023-12-31	Year over year	-670.2%	Revenue: -2850818 Open source Revenue: 500000 Open source
20242024-12-31	Year over year	-492.8%	Revenue: 11198144 Open source Revenue: -2850818 Open source
20252025-12-31	Year over year	-82.3%	Revenue: 1976677 Open source Revenue: 11198144 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -524.7% 2025

Net margin -487.1% 2025

Free cash flow margin -11.7% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	Not reported	Operating Income: -19186834 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -21217976 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	-2,646%	Operating Income: -11325819 Open source Revenue: 428031 Open source
20212021-12-31	Operating margin	19.5%	Operating Income: 3145503 Open source Revenue: 16140838 Open source
20222022-12-31	Operating margin	-2,423.9%	Operating Income: -12119375 Open source Revenue: 500000 Open source
20232023-12-31	Operating margin	629%	Operating Income: -17930957 Open source Revenue: -2850818 Open source
20242024-12-31	Operating margin	-10.3%	Operating Income: -1155035 Open source Revenue: 11198144 Open source
20252025-12-31	Operating margin	-524.7%	Operating Income: -10371379 Open source Revenue: 1976677 Open source
20162016-12-31	Net margin	Not reported	Net Income: -18971508 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: -20982860 Open source Revenue: 0 Open source
20182018-12-31	Net margin	-2,724.1%	Net Income: -11660022 Open source Revenue: 428031 Open source
20212021-12-31	Net margin	-3.9%	Net Income: -634399 Open source Revenue: 16140838 Open source
20222022-12-31	Net margin	-2,151.7%	Net Income: -10758636 Open source Revenue: 500000 Open source
20232023-12-31	Net margin	573.6%	Net Income: -16352082 Open source Revenue: -2850818 Open source
20242024-12-31	Net margin	0.1%	Net Income: 8352 Open source Revenue: 11198144 Open source
20252025-12-31	Net margin	-487.1%	Net Income: -9627505 Open source Revenue: 1976677 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -18281938 Open source Capital Expenditure: 59650 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -16702015 Open source Capital Expenditure: 0 Open source
20182018-12-31	Free cash flow margin	-2,822%	Revenue: 428031 Open source Operating Cash Flow: -12078825 Open source Capital Expenditure: 0 Open source
20212021-12-31	Free cash flow margin	-27.4%	Revenue: 16140838 Open source Operating Cash Flow: -4411303 Open source Capital Expenditure: 7591 Open source
20222022-12-31	Free cash flow margin	-2,420.5%	Revenue: 500000 Open source Operating Cash Flow: -11968819 Open source Capital Expenditure: 133831 Open source
20232023-12-31	Free cash flow margin	416.7%	Revenue: -2850818 Open source Operating Cash Flow: -11865991 Open source Capital Expenditure: 13167 Open source
20242024-12-31	Free cash flow margin	-11.7%	Revenue: 11198144 Open source Operating Cash Flow: -1221233 Open source Capital Expenditure: 90086 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 1976677 Open source Operating Cash Flow: -9760721 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -9.8M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-18281938	Operating Cash Flow: -18281938 Open source
20172017-12-31	Operating cash flow	-16702015	Operating Cash Flow: -16702015 Open source
20182018-12-31	Operating cash flow	-12078825	Operating Cash Flow: -12078825 Open source
20212021-12-31	Operating cash flow	-4411303	Operating Cash Flow: -4411303 Open source
20222022-12-31	Operating cash flow	-11968819	Operating Cash Flow: -11968819 Open source
20232023-12-31	Operating cash flow	-11865991	Operating Cash Flow: -11865991 Open source
20242024-12-31	Operating cash flow	-1221233	Operating Cash Flow: -1221233 Open source
20252025-12-31	Operating cash flow	-9760721	Operating Cash Flow: -9760721 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.3M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-18341588	Operating Cash Flow: -18281938 Open source Capital Expenditure: 59650 Open source
20172017-12-31	Free cash flow	-16702015	Operating Cash Flow: -16702015 Open source Capital Expenditure: 0 Open source
20182018-12-31	Free cash flow	-12078825	Operating Cash Flow: -12078825 Open source Capital Expenditure: 0 Open source
20212021-12-31	Free cash flow	-4418894	Operating Cash Flow: -4411303 Open source Capital Expenditure: 7591 Open source
20222022-12-31	Free cash flow	-12102650	Operating Cash Flow: -11968819 Open source Capital Expenditure: 133831 Open source
20232023-12-31	Free cash flow	-11879158	Operating Cash Flow: -11865991 Open source Capital Expenditure: 13167 Open source
20242024-12-31	Free cash flow	-1311319	Operating Cash Flow: -1221233 Open source Capital Expenditure: 90086 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: -9760721 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

14.9% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	4.9%	Total Liabilities: 1326169 Open source Total Assets: 27342970 Open source
20172017-12-31	Liabilities / assets	25.1%	Total Liabilities: 6345126 Open source Total Assets: 25325114 Open source
20182018-12-31	Liabilities / assets	54.8%	Total Liabilities: 11418280 Open source Total Assets: 20851953 Open source
20212021-12-31	Liabilities / assets	13.2%	Total Liabilities: 6912421 Open source Total Assets: 52482439 Open source
20222022-12-31	Liabilities / assets	5.1%	Total Liabilities: 1907982 Open source Total Assets: 37542922 Open source
20232023-12-31	Liabilities / assets	11.4%	Total Liabilities: 2631629 Open source Total Assets: 23001072 Open source
20242024-12-31	Liabilities / assets	6.7%	Total Liabilities: 1512936 Open source Total Assets: 22510501 Open source
20252025-12-31	Liabilities / assets	14.9%	Total Liabilities: 2528196 Open source Total Assets: 17005612 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.68× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	20.52×	Current Assets: 27208777 Open source Current Liabilities: 1326169 Open source
20172017-12-31	Current assets / current liabilities	3.97×	Current Assets: 25219291 Open source Current Liabilities: 6345126 Open source
20182018-12-31	Current assets / current liabilities	4.63×	Current Assets: 20809203 Open source Current Liabilities: 4491748 Open source
20212021-12-31	Current assets / current liabilities	8.26×	Current Assets: 46379675 Open source Current Liabilities: 5616625 Open source
20222022-12-31	Current assets / current liabilities	20.34×	Current Assets: 34135080 Open source Current Liabilities: 1678126 Open source
20232023-12-31	Current assets / current liabilities	8.69×	Current Assets: 22861224 Open source Current Liabilities: 2631629 Open source
20242024-12-31	Current assets / current liabilities	14.75×	Current Assets: 22321673 Open source Current Liabilities: 1512936 Open source
20252025-12-31	Current assets / current liabilities	6.68×	Current Assets: 16877566 Open source Current Liabilities: 2528196 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 18.21 million Exact value Exact value: -18208378 USD 2015-01-01 – 2015-12-31: -18208378 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2015-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -18208378 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18208378 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420418013981/lpcn-20171231.xml#92336 Filing: 000114420418013981 The citation records this snapshot. The page link may show a newer release later.	−USD 15.36 million Exact value Exact value: -15356304 USD 2015-01-01 – 2015-12-31: -15356304 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2015-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -15356304 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15356304 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420418013981/lpcn-20171231.xml#120242 Filing: 000114420418013981 The citation records this snapshot. The page link may show a newer release later.	USD 28,689 Exact value Exact value: 28689 USD 2015-01-01 – 2015-12-31: 28689 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2015-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 28689 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28689 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420418013981/lpcn-20171231.xml#120638 Filing: 000114420418013981 The citation records this snapshot. The page link may show a newer release later.	−USD 15.38 million Calculation and evidence -15356304 − 28689 USD Exact free cash flow: -15384993 USD 2015-01-01 – 2015-12-31: -15356304 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 28689 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2015-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -15384993 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15356304 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420418013981/lpcn-20171231.xml#120242 Filing: 000114420418013981 Input fundies:CapitalExpenditure: 28689 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420418013981/lpcn-20171231.xml#120638 Filing: 000114420418013981 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 18.97 million Exact value Exact value: -18971508 USD 2016-01-01 – 2016-12-31: -18971508 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2016-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -18971508 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18971508 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#118225 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	−USD 18.28 million Exact value Exact value: -18281938 USD 2016-01-01 – 2016-12-31: -18281938 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2016-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -18281938 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18281938 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#123596 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	USD 59,650 Exact value Exact value: 59650 USD 2016-01-01 – 2016-12-31: 59650 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2016-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 59650 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59650 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#124751 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	−USD 18.34 million Calculation and evidence -18281938 − 59650 USD Exact free cash flow: -18341588 USD 2016-01-01 – 2016-12-31: -18281938 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 59650 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2016-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -18341588 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18281938 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#123596 Filing: 000114420419012434 Input fundies:CapitalExpenditure: 59650 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#124751 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 20.98 million Exact value Exact value: -20982860 USD 2017-01-01 – 2017-12-31: -20982860 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2017-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -20982860 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20982860 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#118079 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	−USD 16.7 million Exact value Exact value: -16702015 USD 2017-01-01 – 2017-12-31: -16702015 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2017-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -16702015 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16702015 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#123392 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2017-01-01 – 2017-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2017-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#124555 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	−USD 16.7 million Calculation and evidence -16702015 − 0 USD Exact free cash flow: -16702015 USD 2017-01-01 – 2017-12-31: -16702015 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2017-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -16702015 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16702015 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#123392 Filing: 000114420419012434 Input fundies:CapitalExpenditure: 0 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#124555 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 11.66 million Exact value Exact value: -11660022 USD 2018-01-01 – 2018-12-31: -11660022 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2018-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -11660022 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11660022 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#117933 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	−USD 12.08 million Exact value Exact value: -12078825 USD 2018-01-01 – 2018-12-31: -12078825 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2018-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -12078825 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12078825 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#123188 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2018-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#124359 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.	−USD 12.08 million Calculation and evidence -12078825 − 0 USD Exact free cash flow: -12078825 USD 2018-01-01 – 2018-12-31: -12078825 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2018-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -12078825 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12078825 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#123188 Filing: 000114420419012434 Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/lpcn-20181231.xml#124359 Filing: 000114420419012434 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 20.96 million Exact value Exact value: -20964819 USD 2020-01-01 – 2020-12-31: -20964819 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2020-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -20964819 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20964819 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315222006353/form10-k.htm#1403616 Filing: 000149315222006353 The citation records this snapshot. The page link may show a newer release later.	−USD 15.3 million Exact value Exact value: -15303098 USD 2020-01-01 – 2020-12-31: -15303098 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2020-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -15303098 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15303098 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315222006353/form10-k.htm#1427403 Filing: 000149315222006353 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 634,399 Exact value Exact value: -634399 USD 2021-01-01 – 2021-12-31: -634399 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2021-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -634399 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -634399 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007178/form10-k.htm#1424197 Filing: 000149315223007178 The citation records this snapshot. The page link may show a newer release later.	−USD 4.41 million Exact value Exact value: -4411303 USD 2021-01-01 – 2021-12-31: -4411303 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2021-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -4411303 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4411303 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007178/form10-k.htm#1242365 Filing: 000149315223007178 The citation records this snapshot. The page link may show a newer release later.	USD 7,591 Exact value Exact value: 7591 USD 2021-01-01 – 2021-12-31: 7591 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2021-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 7591 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7591 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007178/form10-k.htm#1244570 Filing: 000149315223007178 The citation records this snapshot. The page link may show a newer release later.	−USD 4.42 million Calculation and evidence -4411303 − 7591 USD Exact free cash flow: -4418894 USD 2021-01-01 – 2021-12-31: -4411303 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 7591 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2021-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -4418894 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4411303 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007178/form10-k.htm#1242365 Filing: 000149315223007178 Input fundies:CapitalExpenditure: 7591 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007178/form10-k.htm#1244570 Filing: 000149315223007178 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 10.76 million Exact value Exact value: -10758636 USD 2022-01-01 – 2022-12-31: -10758636 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2022-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -10758636 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10758636 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315224009127/form10-k.htm#1495826 Filing: 000149315224009127 The citation records this snapshot. The page link may show a newer release later.	−USD 11.97 million Exact value Exact value: -11968819 USD 2022-01-01 – 2022-12-31: -11968819 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2022-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -11968819 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11968819 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315224009127/form10-k.htm#1511576 Filing: 000149315224009127 The citation records this snapshot. The page link may show a newer release later.	USD 133,831 Exact value Exact value: 133831 USD 2022-01-01 – 2022-12-31: 133831 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2022-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 133831 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 133831 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315224009127/form10-k.htm#1513453 Filing: 000149315224009127 The citation records this snapshot. The page link may show a newer release later.	−USD 12.1 million Calculation and evidence -11968819 − 133831 USD Exact free cash flow: -12102650 USD 2022-01-01 – 2022-12-31: -11968819 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 133831 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2022-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -12102650 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11968819 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315224009127/form10-k.htm#1511576 Filing: 000149315224009127 Input fundies:CapitalExpenditure: 133831 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315224009127/form10-k.htm#1513453 Filing: 000149315224009127 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 16.35 million Exact value Exact value: -16352082 USD 2023-01-01 – 2023-12-31: -16352082 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2023-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -16352082 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16352082 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315225010146/form10-k.htm#1447820 Filing: 000149315225010146 The citation records this snapshot. The page link may show a newer release later.	−USD 11.87 million Exact value Exact value: -11865991 USD 2023-01-01 – 2023-12-31: -11865991 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2023-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -11865991 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11865991 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315225010146/form10-k.htm#1480421 Filing: 000149315225010146 The citation records this snapshot. The page link may show a newer release later.	USD 13,167 Exact value Exact value: 13167 USD 2023-01-01 – 2023-12-31: 13167 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2023-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 13167 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13167 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315225010146/form10-k.htm#1485382 Filing: 000149315225010146 The citation records this snapshot. The page link may show a newer release later.	−USD 11.88 million Calculation and evidence -11865991 − 13167 USD Exact free cash flow: -11879158 USD 2023-01-01 – 2023-12-31: -11865991 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 13167 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2023-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -11879158 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11865991 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315225010146/form10-k.htm#1480421 Filing: 000149315225010146 Input fundies:CapitalExpenditure: 13167 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315225010146/form10-k.htm#1485382 Filing: 000149315225010146 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 8,352 Exact value Exact value: 8352 USD 2024-01-01 – 2024-12-31: 8352 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2024-12-31 LIPOCINE INC. (edgar:1535955) Net Income: 8352 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8352 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1482667 Filing: 000149315226009411 The citation records this snapshot. The page link may show a newer release later.	−USD 1.22 million Exact value Exact value: -1221233 USD 2024-01-01 – 2024-12-31: -1221233 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2024-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -1221233 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1221233 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1292438 Filing: 000149315226009411 The citation records this snapshot. The page link may show a newer release later.	USD 90,086 Exact value Exact value: 90086 USD 2024-01-01 – 2024-12-31: 90086 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIPOCINE INC. · 2024-12-31 LIPOCINE INC. (edgar:1535955) Capital Expenditure: 90086 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 90086 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1295894 Filing: 000149315226009411 The citation records this snapshot. The page link may show a newer release later.	−USD 1.31 million Calculation and evidence -1221233 − 90086 USD Exact free cash flow: -1311319 USD 2024-01-01 – 2024-12-31: -1221233 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 90086 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIPOCINE INC. · 2024-12-31 LIPOCINE INC. (edgar:1535955) Free cash flow: -1311319 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1221233 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1292438 Filing: 000149315226009411 Input fundies:CapitalExpenditure: 90086 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1295894 Filing: 000149315226009411 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 9.63 million Exact value Exact value: -9627505 USD 2025-01-01 – 2025-12-31: -9627505 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIPOCINE INC. · 2025-12-31 LIPOCINE INC. (edgar:1535955) Net Income: -9627505 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9627505 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1482096 Filing: 000149315226009411 The citation records this snapshot. The page link may show a newer release later.	−USD 9.76 million Exact value Exact value: -9760721 USD 2025-01-01 – 2025-12-31: -9760721 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIPOCINE INC. · 2025-12-31 LIPOCINE INC. (edgar:1535955) Operating Cash Flow: -9760721 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T17:07:43Z Snapshot: 9e7f0df0d0de57bda50dc513725d28a32d9eda951b33ce5410c081fd09e4445b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1535955/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9760721 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226009411/form10-k.htm#1291719 Filing: 000149315226009411 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

104 filings · 4,182 latest values · 4,180 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0001535955, 1535955, LPCN, edgar:1535955

Also known as LIPOCINE INC., LIPOCINE INC., Lipocine Inc., MARATHON BAR CORP

LIPOCINE INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation